Basic Information
| LncRNA/CircRNA Name | Cat2184.4 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | qPCR etc. |
| Sample | prostate cancer tissues, cell line (PC5) |
| Expression Pattern | down-regulated |
| Function Description | The expression of Cat2184.4 showed a significant down-regulation in tumor samples (P<0.0001), compared to BPH ones. |
| Pubmed ID | 29671889 |
| Year | 2018 |
| Title | Two long non-coding RNAs, Prcat17.3 and Prcat40, could efficiently discriminate benign prostate hyperplasia from prostate cancer. |
External Links
| Links for Cat2184.4 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |